An observational study examining endothelium-dependent vasodilatation before and after high-dose rosuvastatin therapy

An observational study examining endothelium-dependent vasodilatation before and after high-dose rosuvastatin therapy - Examination of endothelium-dependent vasodilatation before and after high-dose rosuvastatin therapy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000006029

Enrollment

Registered

2011-07-23

Start date

2011-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperlipidemia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with hyperlipidemia who provide written informed consent

Exclusion criteria

Exclusion criteria: 1) Patients with familiar hyperlipidemia 2) Patients with rosuvastatin hypersensitivity 3) Patients with abnormal values of laboratory tests 4) Patients with kidney transplantation or dialysis 5) Patients with administration of cyclosporine 6) Pregnant women, or nursing women 7) Patients with history of hypothyroidism, hereditary myopathy, drug-induced muscle disorder or family history of hereditary myopathy 8) Patients with drug abuse, or alcoholism 9) Patients with malignant disease

Design outcomes

Primary

Measure	Time frame
Endothelium-dependent vasodilatation	—

Countries

Japan

Contacts

Public ContactMinoru Yoshiyama

Osaka City University Graduate School of Medicine Department of Internal medicine and Cardiology

yoshiyama@med.osaka-cu.ac.jp06-6645-3801

Outcome results